Cite
HARVARD Citation
Gisbert, J. et al. (2015). Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Digestive and liver disease. 47 (2), pp. 108-113. [Online].